A

Atea Pharmaceuticals
D

AVIR

4.24000
USD
-0.17
(-3.85%)
مغلق
حجم التداول
12,116
الربح لكل سهم
0
العائد الربحي
-
P/E
-2
حجم السوق
339,314,900
أصول ذات صلة المقالات
المزيد

العنوان: Atea Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Atea Pharmaceuticals Inc is a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.